Related Experiment Video
Updated: Jan 12, 2026

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
Lymph Node Metastasis Frequency and Development of Predictive Model in T1b Gastric Cancer: A Single-Center Study
1Department of Pancreatic and Gastric Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Background:
The optimal management of T1b gastric cancer (GC) remains controversial, largely due to the risk of lymph node metastasis (LNM). This study aimed to clarify the anatomical distribution of LNM and develop a predictive nomogram for patients with T1b GC.
Patients And Methods:
Clinical and pathological data from 1041 patients with pathologically confirmed T1b GC who underwent D2 gastrectomy at a single high-volume center in China were retrospectively analyzed. The frequency and distribution of LNM, including skip metastases, were assessed. Predictive factors identified by logistic regression were incorporated into a nomogram, which was evaluated using receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and calibration plots.
Results:
The overall incidence of LNM was 28.34%, with first- and second-tier rates of 25.4% and 10.3%, respectively. LNM occurred across almost all nodal stations without a consistent anatomical pattern. Lymph node skip metastasis was detected in 2.98% of patients, with no reliable predictors. Importantly, no LNM was observed in well-differentiated tumors ≤ 3 cm, and in moderately to well-differentiated tumors of this size, metastases were confined to first-tier nodes. Multivariable analysis identified female, younger age, larger tumor size, horizontal location, poor differentiation, signet ring cell component, and lymphovascular invasion as independent predictors. The nomogram incorporating these factors demonstrated good discrimination (AUC 0.83; 95% CI 0.80-0.86) and favorable calibration and clinical utility.
Conclusions:
LNM in T1b GC shows a heterogeneous distribution and cannot be predicted by anatomical site alone. Sentinel lymph node biopsy with limited resection may be feasible for carefully selected patients with ≤ 3 cm, moderately to well-differentiated tumors, while D2 gastrectomy remains standard for others. The proposed nomogram may facilitate individualized surgical decision-making but requires external validation.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
03:05Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024